LC-MS/MS Method for the Determination of Vitamin D3 in human plasma published in Pharmaceutical Technology

Media release - FOR IMMEDIATE RELEASE

March 6, 2009

Burnaby, British Columbia – CANTEST Ltd., an analytical laboratory and Contract Research Organization, announced that the European edition of Pharmaceutical Technology has published an article about the determination of vitamin D levels in human plasma, written by CANTEST scientists.

The article, entitled “LC–MS/MS method for the determination of Vitamin D3 in human plasma”, was co-authored by Xuejun Peng, Rong Yi, Amara Pinnawala, Sarah Ostonal, Eliot Chung, Grace van der Gugten, Bernard Nutley and David Gray. Their research resulted in the development of a reliable and accurate method to monitor vitamin D3 levels in the human body when a Vitamin D drug or supplement is taken.

The Canadian Cancer Society is recommending a specific amount of Vitamin D supplementation for Canadians, based on the growing evidence about the link between Vitamin D and reducing risk for colorectal, breast and prostate cancers.

Please click here to view the complete article on Pharmaceutical Technology’s website.

-30-

Don Enns (denns@cantest.com)
President and CEO
604 639 2609

ABOUT CANTEST
Since its incorporation in 1969, CANTEST has grown to become one of Canada's leading analytical and testing laboratories. CANTEST’s success has been predicated upon providing analytical and testing solutions to those who measure and monitor substances that impact our environment and our health. With more than 350 employees, CANTEST offers integrated analytical and specialized testing in support of industries and regulators assessing environmental quality, pharmaceutical/biotechnology efficacy, food quality, and drug residues.
For more information about CANTEST, please visit www.cantest.com.